Olink Holding AB (OLK)
23.98
-0.04
(-0.19%)
USD |
NASDAQ |
May 22, 16:00
23.98
0.00 (0.00%)
After-Hours: 20:00
Olink Cash from Operations (TTM): -42.12M for March 31, 2024
Cash from Operations (TTM) Chart
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | -42.12M |
| December 31, 2023 | -29.98M |
| September 30, 2023 | -27.19M |
| June 30, 2023 | -31.83M |
| March 31, 2023 | -31.24M |
| December 31, 2022 | -30.07M |
| September 30, 2022 | -44.64M |
| Date | Value |
|---|---|
| June 30, 2022 | -36.81M |
| March 31, 2022 | -48.54M |
| December 31, 2021 | -53.69M |
| September 30, 2021 | -49.07M |
| June 30, 2021 | -32.15M |
| March 31, 2021 | -5.338M |
| December 31, 2020 | -6.789M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (TTM) Range, Past 5 Years
-53.69M
Minimum
Dec 2021
-5.338M
Maximum
Mar 2021
-33.53M
Average
-31.99M
Median
Cash from Operations (TTM) Benchmarks
| Thermo Fisher Scientific Inc | 8.928B |
| Abliva AB | -0.7369M |
| Karolinska Development AB | -2.114M |
| Calliditas Therapeutics AB | -- |
| Oncopeptides AB | -30.00M |